Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality
about
Medical Management of Drug-Resistant TuberculosisTuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South AfricaAssociation between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort StudyClinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis.Time to culture conversion and regimen composition in multidrug-resistant tuberculosis treatment.Treatment outcomes for patients with multidrug-resistant tuberculosis in post-earthquake Port-au-Prince, Haiti.Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death.Counting pyrazinamide in regimens for multidrug-resistant tuberculosisConcordance of Mycobacterium tuberculosis fluoroquinolone resistance testing: implications for treatment.Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg, South Africa.Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug ResistanceGyrase Mutations Are Associated with Variable Levels of Fluoroquinolone Resistance in Mycobacterium tuberculosisTreatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru.Concordance of resistance profiles in households of patients with multidrug-resistant tuberculosis.Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa.Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability.Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.Synthetic investigational new drugs for the treatment of tuberculosis.Efficacy and effect of free treatment on multidrug-resistant tuberculosis.Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India.Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian, China.Baseline Predictors of Treatment Outcomes in Children With Multidrug-Resistant Tuberculosis: A Retrospective Cohort Study.Aggressive Regimens Reduce Risk of Recurrence After Successful Treatment of MDR-TB.Totality of outcomes: A different paradigm in assessing interventions for treatment of tuberculosis.WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea.Commentary: a targets framework: dismantling the invisibility trap for children with drug-resistant tuberculosis.Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study.Pulmonary resection for patients with multidrug-resistant tuberculosis based on survival outcomes: a systematic review and meta-analysis.Outcomes of pulmonary MDR-TB: impacts of fluoroquinolone resistance and linezolid treatment.Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis.
P2860
Q26801601-44235EA4-7F08-4EE5-8062-3B73BC1DAF01Q28550587-0E611602-C9B9-4108-81F3-F80FB95A3B21Q28552001-3758C3C8-29ED-4636-98DF-E4F09FB9886BQ33760793-F2F7D9CE-5436-4CE8-8781-3189BA9FD889Q34216020-3AE94222-3E67-4127-9AE9-FD7C90B3637DQ34281547-E86BC13B-BCC8-4064-B5BA-D9981B82ADF7Q35008349-5DA5D7B8-EA3C-4406-AA56-358E7C905086Q35565162-C16C679E-189B-403B-8489-B86CECCD6307Q35800272-89E113AC-4731-43A7-9E05-CF53CCBFF398Q35825237-7DD277D1-2BCA-4563-B134-C78E2EE1AF2AQ36273236-C420B9FE-C9EE-4B70-A01C-6B41C874120CQ36497854-F3A98F55-32C4-4594-B393-5B42FC403605Q36620922-D48EEB32-7248-4853-98D9-618DE7CECA6EQ37375069-356732F3-D35F-4A7C-87BE-99030A4A2966Q37473031-5BB0D61B-A1D0-448F-9AED-D9327C935701Q38173336-79761A1F-ED4E-4174-A194-69184F6259A4Q38261230-DC2AD6FB-034A-402E-908E-532D19509E2CQ38383242-6EE596A6-148A-46A8-94AC-258F0E65BCEFQ38635790-9D37ECAE-73C7-4266-9871-211EF15132F1Q38718198-1AE467A6-25E7-4169-89CE-82B0DB403775Q38827594-3FA54845-BE18-4B64-BE8E-587233684091Q38874630-2CA6B6BD-DC04-45E5-9D35-CE9939CD8662Q39560188-0E43CB60-09DC-499F-8229-3FEC94112BC4Q39780875-B2EBEDB8-F37C-4CB8-8B7D-13459776FD71Q40083707-06DBCAB7-C297-4338-A4E3-1B1E98607E70Q41658421-6ED4C33E-643F-4970-BA8B-CAF2B0840BEAQ41744320-1B031ADD-E5ED-487A-A0C1-89D75ACB23F2Q41987738-2CEC0CDB-2410-44E9-ADBB-172B5D8B9449Q47829817-02D2E66E-0F1D-4CFA-82D0-F45F50A6CAB2Q53205517-8604D530-2A95-4997-B147-518F9F39696DQ55208580-B9C73FED-C56B-4F20-A788-B6AFF0036454
P2860
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality
@ast
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality
@en
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality
@nl
type
label
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality
@ast
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality
@en
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality
@nl
prefLabel
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality
@ast
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality
@en
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality
@nl
P2093
P2860
P3181
P1433
P1476
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality
@en
P2093
Alexander Sloutsky
Arielle W Tolman
Carole D Mitnick
Dalia Guerra
Eda Palacios
Epifanio Sanchez
Felix A Alcantara Viru
Hamish S F Fraser
Jaime N Bayona
Jennifer J Furin
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0058664
P407
P577
2013-01-01T00:00:00Z